Young Adults clinical trials

Explore recruiting young adults clinical trials.

Recruiting young adults studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Young Adults trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Durvalumab Monotherapy or Durvalumab in Combination with Tremelimumab in Pediatric Patients with Advanced Solid Tumors and Hematological Malignancies

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Austria, Belgium, Netherlands, Sweden, France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

SIRAVA: Five-year boostability after single-visit single-dose intramuscular rabies pre-exposure prophylaxis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A5481092: PHASE 1/2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE OR IN COMBINATION WITH TOPOTECAN AND CYCLOPHOSPHAMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS

Sweden, France, Czechia, Slovakia, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Young Adults trials by city

Young Adults in Toronto Young Adults in Vancouver Young Adults in Montreal Young Adults in Calgary Young Adults in Edmonton Young Adults in Ottawa Young Adults in Winnipeg Young Adults in Quebec City Young Adults in Hamilton Young Adults in Kitchener Young Adults in London Young Adults in Halifax Young Adults in New York Young Adults in Los Angeles Young Adults in Chicago Young Adults in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease